Literature DB >> 2889930

Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City.

D C Des Jarlais, R Stoneburner, P Thomas, S R Friedman.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--complications; Americas; Developed Countries; Developing Countries; Diseases; Epidemiologic Methods; Hiv Infections; Morbidity--changes; New York; North America; Northern America; Population At Risk; Research Methodology; Research Report; United States; Viral Diseases

Mesh：

Year:  1987        PMID： 2889930     DOI： 10.1016/s0140-6736(87)92586-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

2.  Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma.

Authors:  G Cathomas; C E McGandy; L M Terracciano; P H Itin; G De Rosa; F Gudat
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 3.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94.

Authors:  S Franceschi; L Dal Maso; A Lo Re; D Serraino; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Nitrite inhalants: history, epidemiology, and possible links to AIDS.

Authors:  H W Haverkos; A N Kopstein; H Wilson; P Drotman
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

6.  Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.

Authors:  F D Goebel; D Goldstein; M Goos; H Jablonowski; J S Stewart
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.